Spinal cord injury (SCI) rostral to the lumbar locomotor center disrupts communication between the brain and the spinal ...

Global Neuromodulation Devices Market OverviewThe global neuromodulation devices market is poised to witness substantial ...

Medtronic MDT is set to release second-quarter fiscal 2026 results on Nov. 18, before the market opens. The MedTech giant posted earnings per share (EPS) of $1.26 in the last reported quarter, which ...

Treating chronic neuropathic pain with spinal cord stimulation may help prevent excess mortality associated with chronic pain, a new study from the University of Eastern Finland and Kuopio University ...

All participants undergo a baseline assessment on day 1; in the EES+PT group, an epidural electrode is implanted on day 2, stimulation programs are initiated on postoperative day 1 and iteratively ...

New technology is helping people with paralysis move again, and it doesn't involve surgery, needles or drugs. It's a first-of-its-kind non-invasive spinal cord stimulation therapy, and it's now ...

While there is no cure for Parkinson’s disease, there’s now a better way to control its involuntary muscle movements. In February, the FDA approved Medtronic’s BrainSense adaptive deep brain ...

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first ...

How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...